Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 46 for:    Asklepios BioPharmaceutical

AAV2/8-LSPhGAA in Late-Onset Pompe Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03533673
Recruitment Status : Recruiting
First Posted : May 23, 2018
Last Update Posted : February 21, 2021
Sponsor:
Collaborators:
Duke University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by (Responsible Party):
Asklepios Biopharmaceutical, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : June 2023